Sofinnova Capital VII FCPR, 10% Owner at Shockwave Medical, Inc. (SWAV), sold 456,556 shares at $51.23 ($23.0M) on 2020-08-05, disclosed to the SEC on 2020-08-05.
Scheduled sale ($23.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 85,549 | $4.3M | 18.6% |
| 2 | $50.01 | 85,549 | $4.3M | 18.6% |
| 3 | $50.01 | 33,323 | $1.7M | 7.3% |
| 4 | $50.01 | 33,323 | $1.7M | 7.3% |
| 5 | $50.46 | 73,860 | $3.7M | 16.2% |
| 6 | $50.46 | 73,860 |
| $3.7M |
| 16.2% |
| 7 | $51.23 | 35,546 | $1.8M | 7.9% |
| 8 | $51.23 | 35,546 | $1.8M | 7.9% |
| Total | $50.35 avg | 456,556 | $23.0M | 100% |
| Filing → |
| SWAV | SELL | 2020-08-14 | $1.5M | — | Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-06-11 | $16.0M | — | Filing → |